₹1654.5
+1.44% today
· 30d +4.32%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for AUROPHARMA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹8853 Cr
+5.62% YoY
NET PROFIT
₹921 Cr
+1.99% YoY
OPM
20.84%
-1.78pp YoY
EPS
₹15.86
PE 25.95
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-16.8%, h2=-16.4%, h3=-10.7% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
ML Forward Growth Predictions 🔒
74
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
100
Valuation
REASONABLE
60
Growth
STEADY
67
Profitability
DECENT
68
Technicals
NEUTRAL
62
Risk
LOW
90
Key Stats
TTM PE
25.95
P/B
2.54
52W HIGH
₹1703.0
OFF HIGH
-2.85%
DIV YIELD
0.24%
MKT CAP
₹95438 Cr
◉ Active Signals
MACDNeutral-0.4041
RSI(14)Neutral56.97
Near 52W HighBullish-2.85
Street Consensus
28 analysts₹1678.32
mean target
Low ₹1270.0Now ₹1654.5High ₹1955.0
⧉ Strategy Fit 🔒